Evidence map›Paper›PMID 31780185›Full record

ArticlePsychoneuroendocrinology2020

The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause.

Allison Kimball, Laura E Dichtel, Maren B Nyer, David Mischoulon, Lauren B Fisher, Cristina Cusin, Christina M Dording, Nhi-Ha Trinh, Albert Yeung, Melanie S Haines and 7 more

Open access · greenAbstract read
In one paragraph

Article in Psychoneuroendocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Effects of Micronized Progesterone in Menopausal Hormone Replacement Therapy on Sleep.The journal of obstetrics and gynaecology research · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Neurosteroids: a lifelong impact on brain health.Frontiers in behavioral neuroscience · 2025
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Allison KimballNeuroendocrine Unit, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Laura E DichtelNeuroendocrine Unit, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Maren B NyerDepression Clinical and Research Program, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
David MischoulonDepression Clinical and Research Program, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Lauren B FisherDepression Clinical and Research Program, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Cristina CusinDepression Clinical and Research Program, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Christina M DordingDepression Clinical and Research Program, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Nhi-Ha TrinhDepression Clinical and Research Program, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Albert YeungDepression Clinical and Research Program, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Melanie S HainesNeuroendocrine Unit, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Joshua C SungNeuroendocrine Unit, Massachusetts General Hospital, Boston, MA, USA.
Graziano PinnaThe Psychiatric Institute, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA.
Ann M RasmussonNational Center for PTSD, Department of Veterans Affairs, VA Boston Healthcare System, and Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA.
Linda L CarpenterButler Hospital, Brown Department of Psychiatry and Human Behavior, Providence, RI, USA.
Maurizio FavaDepartment of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Anne KlibanskiNeuroendocrine Unit, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Karen Klahr MillerNeuroendocrine Unit, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA. Electronic address: KKMiller@mgh.harvard.edu.
Massachusetts General Hospital · USHarvard University · USProvidence College · USUniversity of Illinois Chicago · USVA Boston Healthcare System · US

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
ZD6416 Analgesic--Painful Distal Symmetrical PolyneuropaM01RR001066 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, EMERY N · 1985 to 2008
$37.4M
TRAINING PROGRAM IN ENDOCRINOLOGY AND DIABETEST32DK007028 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Karen K Miller · 1986 to 2026
$18.5M
Growth Hormone and Cardiovascular DiseaseK24HL092902 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MILLER, KAREN K · 2010 to 2019
$1.6M
Relative Sarcopenia and Cardiometabolic Risk in Young Adults with ObesityK23DK115903 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI HAINES, MELANIE SCHORR · 2017 to 2021
$1.1M
The Growth Hormone and Insulin-like Growth Factor-1 Axis in Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisK23DK113220 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI DICHTEL, LAURA ELISABETH · 2017 to 2021
$1.1M
1/2-Collaborative Study: Testosterone Antidepressant Augmentation in WomenR34MH099315 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI FAVA, MAURIZIO, MILLER, KAREN K · 2013 to 2015
$783k
2/2 Collaborative Study: Testosterone Augmentation in WomenR34MH099310 · NIMH · BUTLER HOSPITAL (PROVIDENCE, RI) · PI CARPENTER, LINDA L · 2013 to 2015
$633k
NCATS NIH HHS UL1 TR001102NCRR NIH HHS M01 RR001066NHLBI NIH HHS K24 HL092902NIDDK NIH HHS K23 DK113220NIDDK NIH HHS K23 DK115903NIDDK NIH HHS T32 DK007028NIMH NIH HHS R34 MH099310NIMH NIH HHS R34 MH099315
6 · The paper itself

Abstract

The neuroactive steroid 3α-5α-tetrahydroprogesterone (allopregnanolone), a metabolite of progesterone, is a positive allosteric modulator of GABA

Indexed as

AdultAgedFemaleFollicular PhaseHumansLuteal PhaseMenopauseMiddle AgedPregnanoloneProgesteroneYoung AdultPregnanoloneProgesteroneAllopregnanoloneMenopauseMenstrual cycleNeuroactive steroids

Identifiers

PMID31780185
PMCPMC6935417
OpenAlexW2989076120

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.